Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oligodendroglioma × Introns × Clear all

Sponsor

Conditions

Melanoma 12 Multiple Myeloma 3 Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Leukemia-Lymphoma, Adult T-Cell 1 Leukemia 1 Hematologic Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Temozolomide 14 Bevacizumab 11 Erlotinib Hydrochloride 5 Radiotherapy 4 Carboplatin 4 Irinotecan 3 Immunoglobulin G 3 Disulfides 3 poly ICLC 2 palbociclib 2 etoposide phosphate 2 Vincristine 2 Sunitinib 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2 veliparib 1 varlilumab 1 vandetanib 1 trebananib 1 trametinib 1 terameprocol 1 temsirolimus 1 tandutinib 1 selinexor 1 romidepsin 1 picropodophyllin 1 pemigatinib 1 niraparib 1 nintedanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡